Literature DB >> 12647265

Angiotensin II upregulates the expression of vasopressin V2 mRNA in the inner medullary collecting duct of the rat.

Norman L M Wong1, Joseph K C Tsui.   

Abstract

Previous in vivo studies in cardiomyopathic hamsters suggested that the expression of vasopressin (AVP) V2 mRNA is up- regulated by angiotensin II. The present study was performed to determine whether angiotensin II plays a role in regulating the expression of AVP V2 mRNA and aquaporin-2 (AQP2) mRNA in the inner medullary collecting duct (IMCD) of the male Wistar rat. The expression of AVP V2 mRNA and AQP2 mRNA in the IMCD was measured by competitive reverse-transcriptase polymerase chain reaction (RT-PCR). Six groups of experiments were performed. In the first group, we incubated IMCD with 3 different doses of angiotensin II (10(-11), 10(-9) and 10(-7) mol/L). Angiotensin II caused a significant increase in the AVP V2 mRNA in a dose-dependent manner but its effect on AQP2 mRNA was modest. This effect of angiotensin II was inhibited by angiotensin II receptor antagonist, [Sar1,Ile8]-angiotensin II. To examine the role of PKA in mediating an increase in AVP V2 mRNA expression, we incubated IMCD with 10(-7) and 10(-11) M of angiotensin II in the presence of a specific protein kinase A (PKA) inhibitor, Rp diasteroisomer of adenosine 3'-5'-cylic monophosphothionate (Rp-cAMPS). The angiotensin II-induced upregulation of V2 mRNA was abolished. In the fourth group, we examined the effect of protein kinase C (PKC) inhibition on V2 mRNA expression. The upregulation of V2 mRNA induced by angiotensin II was greatly exaggerated when IMCD was incubated with angiotensin II and RO-31-8220 (PKC inhibitor). In the fifth and sixth groups of studies, we determined the direct effect of PKA and PKC on regulating the expression of V2 mRNA and AQP2 mRNA in the IMCD, respectively. Dibutryl cAMP stimulated an upregulation in the expression of V2 mRNA and AQP2 mRNA, whereas phorbol esters suppressed the expression of V2 mRNA. These results suggested that PKA stimulates and PKC suppresses the expression of V2 mRNA in the IMCD of the kidney. Copyright 2003, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12647265     DOI: 10.1053/meta.2003.50047

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  16 in total

Review 1.  Regulation of AQP2 in Collecting Duct : An emphasis on the Effects of Angiotensin II or Aldosterone.

Authors:  Byung-Heon Lee; Tae-Hwan Kwon
Journal:  Electrolyte Blood Press       Date:  2007-06-30

2.  Interaction between vasopressin and angiotensin II in vivo and in vitro: effect on aquaporins and urine concentration.

Authors:  Weidong Wang; Chunling Li; Sandra Summer; Sandor Falk; Robert W Schrier
Journal:  Am J Physiol Renal Physiol       Date:  2010-06-24

3.  Heterologous downregulation of vasopressin type 2 receptor is induced by transferrin.

Authors:  Richard Bouley; Paula Nunes; Billy Andriopoulos; Margaret McLaughlin; Matthew J Webber; Herbert Y Lin; Jodie L Babitt; Thomas J Gardella; Dennis A Ausiello; Dennis Brown
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-12

4.  Effects of the renal medullary pH and ionic environment on vasopressin binding and signaling.

Authors:  Elena A Zalyapin; Richard Bouley; Udo Hasler; Jean-Pierre Vilardaga; Herbert Y Lin; Dennis Brown; Dennis A Ausiello
Journal:  Kidney Int       Date:  2008-08-27       Impact factor: 10.612

5.  Angiotensin II and hypertonicity modulate proximal tubular aquaporin 1 expression.

Authors:  Richard Bouley; Zaira Palomino; Shiow-Shih Tang; Paula Nunes; Hiroyuki Kobori; Hua A Lu; Winnie W Shum; Ivan Sabolic; Dennis Brown; Julie R Ingelfinger; Flavia F Jung
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-23

6.  Abnormal function of the vasopressin-cyclic-AMP-aquaporin2 axis during urine concentrating and diluting in patients with reduced renal function. A case control study.

Authors:  Erling B Pedersen; Ingrid M Thomsen; Thomas G Lauridsen
Journal:  BMC Nephrol       Date:  2010-10-05       Impact factor: 2.388

Review 7.  Classical Renin-Angiotensin system in kidney physiology.

Authors:  Matthew A Sparks; Steven D Crowley; Susan B Gurley; Maria Mirotsou; Thomas M Coffman
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

Review 8.  Losartan chemistry and its effects via AT1 mechanisms in the kidney.

Authors:  Feichao Xu; Caiping Mao; Yujuan Liu; Lei Wu; Zhice Xu; Lubo Zhang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

9.  Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease.

Authors:  Federica Piani; Trenton Reinicke; Yuliya Lytvyn; Isabella Melena; Leif E Lovblom; Vesta Lai; Josephine Tse; Leslie Cham; Andrej Orszag; Bruce A Perkins; David Z I Cherney; Petter Bjornstad
Journal:  J Diabetes Complications       Date:  2020-11-26       Impact factor: 2.852

10.  Increased renal sodium absorption by inhibition of prostaglandin synthesis during fasting in healthy man. A possible role of the epithelial sodium channels.

Authors:  Thomas G Lauridsen; Henrik Vase; Jørn Starklint; Carolina C Graffe; Jesper N Bech; Søren Nielsen; Erling B Pedersen
Journal:  BMC Nephrol       Date:  2010-10-28       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.